Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for premature infants with necrotizing enterocolitis
IRCT20250908067173N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of melatonin in necrotizing enterocolitis (NEC) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Incidence of definite necrotizing enterocolitis, Need for bowel resection and 12 more. Started Oct 2025; status: completed.
02
Drugs
melatonin
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on IRCT20250908067173N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250908067173N1.